Suprathel Versus Xeroform for the Management of Skin Graft Donor Sites

Stopped early · Not applicable

Conditions studied: Burns, Skin Graft Complications, Skin; Deformity

In brief

The investigators aim to study whether Suprathel, a synthetic temporary skin substitute developed by PolyMedics Innovations GmBH aids in the management of patient pain and wound healing when compared to the current standard dressing used of a primary Xeroform dressing.

Key facts

Study ID

NCT04014400

Run by

University of Colorado, Denver

People needed

10

Starts

2019-07-07

Expected to finish

2020-07-23

Last updated by the study team

2020-10-22

Who can join

Age: 0 and older, up to 80. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children 31 days old -17 years old
• Have a burn injury or open wound of any percentage TBSA
• Require a skin graft

You may not qualify if…

• allergy to one of the dressings involved in the study,
• burn in close proximity to the donor site,
• the donor site has been harvested in a previous surgery,
• prisoners,
• children under the protection of the department of human services,
• pregnant women,
• those with impaired decision-making capacity.

Where it is running

• Children's Hospital Colorado — Aurora, Colorado, United States
• University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.